Clinical Trial

A Trial in Mini-invasive Pilonidal Sinus Disease Surgery

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Pilonidal sinus disease is a chronic acquired disease leading to significant morbidity and healthcare costs in young man and women. Despite different treatment methods, the disease relatively often leads to postoperative complications and recurrence.(8). Advantages of mini-invasive techniques include: quicker recovery and earlier return to work and high patient satisfaction. Randomized studies are rare and this applies especially to newer mini-invasive techniques. The purpose of the investigators prospective study is to randomly compare the mini-invasive laser ablation technique to the mini-invasive fibrin glue treatment in pilonidal sinus disease surgery.
Trial Details
NCT Number NCT06964763
Lead Sponsor Helsinki University Central Hospital
Conditions Pilonidal Disease
Enrollment 188 participants
Start Date 2023-09-01
Primary Completion 2029-06-17 (estimated)
Study Completion 2029-12-17 (estimated)
Updated on ClinicalTrials.gov 2025-05-09